These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 18945405)

  • 1. Human papillomavirus vaccine policy and delivery in Latin America and the Caribbean.
    Andrus JK; Lewis MJ; Goldie SJ; García PJ; Winkler JL; Ruiz-Matus C; de Quadros CA
    Vaccine; 2008 Aug; 26 Suppl 11():L80-7. PubMed ID: 18945405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recommendations for cervical cancer prevention in Latin America and the Caribbean.
    Muñoz N; Franco EL; Herrero R; Andrus JK; de Quadros C; Goldie SJ; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 11():L96-L107. PubMed ID: 18945407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of human papillomavirus vaccine acceptability in Latin America and the Caribbean.
    Winkler JL; Wittet S; Bartolini RM; Creed-Kanashiro HM; Lazcano-Ponce E; Lewis-Bell K; Lewis MJ; Penny ME
    Vaccine; 2008 Aug; 26 Suppl 11():L73-9. PubMed ID: 18945404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Pan American Health Organization strategy for cervical cancer prevention and control in Latin America and the Caribbean.
    Luciani S; Andrus JK
    Reprod Health Matters; 2008 Nov; 16(32):59-66. PubMed ID: 19027623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mathematical models of cervical cancer prevention in Latin America and the Caribbean.
    Goldie SJ; Diaz M; Constenla D; Alvis N; Andrus JK; Kim SY
    Vaccine; 2008 Aug; 26 Suppl 11():L59-72. PubMed ID: 18945403
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integration of human papillomavirus vaccination and cervical cancer screening in Latin America and the Caribbean.
    Franco EL; Tsu V; Herrero R; Lazcano-Ponce E; Hildesheim A; Muñoz N; Murillo R; Sánchez GI; Andrus JK
    Vaccine; 2008 Aug; 26 Suppl 11():L88-95. PubMed ID: 18945406
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Benefits, cost requirements and cost-effectiveness of the HPV16,18 vaccine for cervical cancer prevention in developing countries: policy implications.
    Goldie SJ; O'Shea M; Diaz M; Kim SY
    Reprod Health Matters; 2008 Nov; 16(32):86-96. PubMed ID: 19027626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for human papillomavirus exposure and co-factors for cervical cancer in Latin America and the Caribbean.
    Almonte M; Albero G; Molano M; Carcamo C; García PJ; Pérez G
    Vaccine; 2008 Aug; 26 Suppl 11():L16-36. PubMed ID: 18945400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progress toward implementation of human papillomavirus vaccination--the Americas, 2006-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(40):1382-4. PubMed ID: 21993342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Global implementation of human papillomavirus (HPV) vaccine: lessons from hepatitis B vaccine.
    Kane MA
    Gynecol Oncol; 2010 May; 117(2 Suppl):S32-5. PubMed ID: 20129654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical cancer screening programs in Latin America and the Caribbean.
    Murillo R; Almonte M; Pereira A; Ferrer E; Gamboa OA; Jerónimo J; Lazcano-Ponce E
    Vaccine; 2008 Aug; 26 Suppl 11():L37-48. PubMed ID: 18945401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Introduction of vaccination against human papillomavirus in developing countries: update and perspectives].
    Hessel L
    Med Trop (Mars); 2009 Aug; 69(4):323-6. PubMed ID: 19725378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New approaches to cervical cancer screening in Latin America and the Caribbean.
    Herrero R; Ferreccio C; Salmerón J; Almonte M; Sánchez GI; Lazcano-Ponce E; Jerónimo J
    Vaccine; 2008 Aug; 26 Suppl 11():L49-58. PubMed ID: 18945402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chapter 15: HPV vaccine use in the developing world.
    Kane MA; Sherris J; Coursaget P; Aguado T; Cutts F
    Vaccine; 2006 Aug; 24 Suppl 3():S3/132-9. PubMed ID: 16950000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recommendations for cervical cancer prevention in Asia Pacific.
    Garland SM; Cuzick J; Domingo EJ; Goldie SJ; Kim YT; Konno R; Parkin DM; Qiao YL; Sankaranarayanan R; Stern PL; Tay SK; Bosch FX
    Vaccine; 2008 Aug; 26 Suppl 12():M89-98. PubMed ID: 18945418
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus and cervical cancer in Australasia and Oceania: risk-factors, epidemiology and prevention.
    Garland SM; Brotherton JM; Skinner SR; Pitts M; Saville M; Mola G; Jones RW
    Vaccine; 2008 Aug; 26 Suppl 12():M80-8. PubMed ID: 18945417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strengthening vaccination policies in Latin America: an evidence-based approach.
    Tapia-Conyer R; Betancourt-Cravioto M; Saucedo-Martínez R; Motta-Murguía L; Gallardo-Rincón H
    Vaccine; 2013 Aug; 31(37):3826-33. PubMed ID: 23357196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cervical cancer in Latin America and the Caribbean: the problem and the way to solutions.
    Villa LL
    Cancer Epidemiol Biomarkers Prev; 2012 Sep; 21(9):1409-13. PubMed ID: 22956726
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of human papillomavirus immunization in the developing world.
    Kane MA; Serrano B; de Sanjosé S; Wittet S
    Vaccine; 2012 Nov; 30 Suppl 5():F192-200. PubMed ID: 23199963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus vaccine legislation in Kentucky: a policy analysis.
    Dekker RL
    Policy Polit Nurs Pract; 2008 Feb; 9(1):40-9. PubMed ID: 18492941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.